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LETTER TO THE EDITOR
Cardiac CTA for Evaluation of Prosthetic
Valve Dysfunction
The objective of the study was to evaluate the
accuracy of cardiac computed tomography angiog-
raphy (CTA) for the diagnosis of prosthetic valve
dysfunction (PVD) compared with surgery.
Patients after heart valve repair who were referred
for clinically indicated CTA (coronary artery or
bypass graft evaluation, suspected PVD with or
without paravalvular involvement, or other surgical
planning) were included in our retrospective multi-
center study (4 centers). All patients underwent
surgery. CTA was compared to transesophageal
echocardiography (TEE) in a subset of patients who
had Core-Lab TEE within 8 days, using a standard-
ized protocol (1) by an observer with >10 years of
experience.
A 64- or 128-slice CTA was performed, and images
were transferred to the Core-Lab. Multiphase data
sets (entire cardiac cycle) were analyzed by 2 inde-
pendent and blinded observers (>10 years’ and >1
year of experience) by using multiplanar reformations
(MPR), 3-dimensional volume rendering technique
(VRT) and 4-cine loops for:
1. paravalvular leakage: visible contrast agent
outﬂow at the annulus or from above to
below (<1 cm);
2. pseudoaneurysm: round cavity of >1 cm ﬁlled with
contrast agent;
3. paravalvular abscess: dense paravalvular inﬁltra-
tion with 0 to 40 Hounsﬁeld units (HU) with or
without a surrounding layer of tissue with contrast
uptake (“deﬁnite”) or (“uncertain” >40 HU);
4. mass: hypodense lesion (“vegetation,” “thrombus/
pannus,” or “unclear”);
5. dehiscence: loosening of the prosthesis anchor
within the annulus (>10);
6. structural bioprosthetic valve degeneration, leaﬂet
thickening with or without calciﬁcation, and
“restricted leaﬂet motion”; and
7. mechanical “stuck valve,” resulting in <70 leaﬂet
opening angle.
A total of 51 patients (65.4  12.1 years of age; 23.5%
female) with 58 prosthetic heart valves (PHV) (37.5%
mechanical, 57.1% bioprosthetic, 5.4% mitral annu-
loplasty) were included. The time interval between
CTA and surgery was 29.2  42.6 days and 4.06  2.8
days between TEE and CTA. Mean PHV age was 7.7 
5.2 years (range 0.5 to 27.0 years), and infection rate
was 29.4%.
CTA VERSUS SURGERY (51 PATIENTS)
The concordance of CTA for diagnosis of PVD was
kappa ¼ 0.81 (95% conﬁdence interval [CI]: 0.54 to
1.1) per patient and a kappa ¼ 0.93 (95% CI: 0.83 to
1.03) per lesion.
CTA detected 12 of 13 paravalvular leaks (92.3%)
and 10 of 10 pseudoaneurysms (100%). Two pseu-
doaneurysms were not visualized by TEE (n ¼ 1
large cranial extension/ascending aorta; n ¼ 1 basal/
posterior mitral annulus).
CTA identiﬁed 10 abscesses (4 false positives rated
as “uncertain”), whereas 18F-labeled ﬂuorodeox-
yglucose positron emission tomography (2) correctly
excluded 2 abscesses.
CTA diagnosed 22 of 25 masses (88%; 13 thrombi/
pannus, 8 vegetations, and 1 unclear (ruptured
chordae with retracted papillary muscle). Six panni
could not be visualized by TEE due to metal rever-
beration artifacts, although an increased trans-
valvular pressure gradient was observed. Two panni
(n ¼ 1 patient of with 2 bioprosthetic valves) were
incorrectly diagnosed by CTA as a “beam hardening
artifact” (2 mm) and vegetation (3 mm size),
respectively.
Twelve of 12 dehiscences (100%) were correctly
diagnosed by CTA. In 4 patients, the full circumfer-
ential extent was underestimated by TEE, although
“paravalvular leak” was reported.
Sixteen of 17 instances of structural bioprosthetic
valve degeneration (94.1%) were detected by CTA, as
were 2 of 2 mechanical “stuck valves” (100%) and 3 of
3 abnormalities (100%) after mitral annuloplasty,
respectively.
CTA AND TEE VERSUS SURGERY
(23 PATIENTS)
The accuracy of TEE was c ¼ 0.735 (95% CI: 0.54 to
0.88) and c ¼ 0.912 (95% CI: 0.74 to 0.98; p ¼ 0.003,
receiver operating characteristic analysis) for CTA.
In summary, our data show a high accuracy of CTA
for detecting PVD, using surgery as the reference
standard, particularly for the assessment of para-
valvular pathologies (paravalvular leakage, abscess,
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pseudoaneurysm, or dehiscence) (Figure 1A) and
identiﬁcation of thrombi/pannus. CTA further clari-
ﬁed the cause of increased transvalvular pressure
gradients (Figure 1B, thrombus/pannus) on echocar-
diography. CTA added value to 2-dimensional TEE
for the visualization of the full circumferential extent
of dehiscence. In addition, CTA allowed for comple-
mentary evaluation of native coronary arteries and
bypass grafts.
The study was limited by the absence of 3-
dimensional TEE, which should be superior to 2-
dimensional TEE for PHV visualization and diagnostic
performance.
In conclusion, we advocate TEE as the primary
imaging tool for PVD in alignment with the American
Heart Association scientiﬁc statement (3), with CTA
as part of a multimodality diagnostic work-up, with
speciﬁc recommendations for suspected paravalvular
involvement, to characterize pathologies and to fully
deﬁne the involved anatomic territory; unclear
PHV dysfunction on TEE (e.g., increased pressure
gradient) without a morphological correlate for
thrombus/pannus detection; and PHV mass charac-
terization (thrombus/pannus, vegetation vs. calciﬁ-
cation). In view of the high risk of PHV revision
surgery, multimodality imaging may be justiﬁed in
these subgroups.
Gudrun Feuchtner, MD*
Fabian Plank, MD
Silvana Mueller, MD
Thomas Schachner, MD
Nikolaos Bonaros, MD
Philipp Burghard
FIGURE 1 Prosthetic Valve Dysfunction
(A) A 79-year-old man with an infected bioprosthesis. CTA (left/mid) shows paravalvular abscess, A; pseudoaneurysm, P; dehiscence, D;
and vegetation, V. Two-dimensional TEE is shown (right). (B) A 72-year-old man with a mechanical prosthesis experiencing increased
transvalvular pressure gradient. CTA is shown as mixed thrombus/pannus (arrow), MPR (left) and 3D-VRT (right). CTA ¼ computed
tomography angiography; MPR ¼ multiplanar reformations; TEE ¼ transesophageal echocardiography; VRT ¼ volume rendering technique.
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